Clever Leaves Holdings Inc. (CLVR) Stock Analysis

Clever Leaves Holdings Inc. (CLVR) Healthcare & Pipeline Overview

Clever Leaves Holdings Inc., founded in 2017, operates in the global cannabis market, focusing on cannabinoid and non-cannabinoid products. With a presence in both international cannabinoid markets and the U.S. nutraceutical sector, the company faces challenges typical of the evolving cannabis industry, including regulatory hurdles and intense competition.

What Is the Investment Thesis for CLVR?

Investing in Clever Leaves Holdings Inc. presents a high-risk, high-reward scenario. The company operates in the rapidly evolving cannabis industry, offering potential for significant growth but also exposing investors to substantial risks. Key value drivers include the expansion of its international cannabinoid operations and the growth of its nutraceutical business in the U.S. However, the company's negative profit margin of -102.8% and OTC market listing raise concerns about its financial stability and liquidity. Growth catalysts include potential regulatory changes in key markets and successful product launches. Investors should carefully consider the company's financial position, competitive landscape, and regulatory environment before investing. The high beta of 4.48 indicates significant volatility.

Based on FMP financials and quantitative analysis

CLVR Key Highlights

Clever Leaves operates in the Cannabinoid segment, focusing on cultivation, extraction, and distribution of cannabis products internationally.

• The company's Non-Cannabinoid segment formulates and sells nutraceuticals and wellness products in the United States.
• Clever Leaves was founded in 2017 and is based in Boca Raton, Florida.
• The company has a gross margin of 37.6%.
• Clever Leaves has 296 employees.

Who Are CLVR's Competitors?

CLVR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CLVR's Key Strengths?

Diversified product portfolio (cannabinoid and non-cannabinoid).

• International presence in key cannabis markets.
• Established distribution network in the U.S. nutraceutical market.
• Expertise in cannabis cultivation and extraction.

What Are CLVR's Weaknesses?

Negative profit margin.

• High beta indicating significant volatility.
• OTC market listing raises liquidity concerns.
• Dependence on regulatory changes in the cannabis industry.

What Could Drive CLVR Stock Higher?

CLVR catalyst: Potential regulatory changes in key international markets could open new opportunities for cannabinoid product sales.

• Successful product launches in the U.S. nutraceutical market could drive revenue growth.
• Expansion of the company's distribution network in the United States.
• Strategic partnerships and acquisitions to expand market reach.
• Research and development efforts to create innovative and differentiated products.

What Are the Key Risks for CLVR?

Financial-distress signal — its Altman Z-Score of -10.11 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-55.4%) — the business is not currently generating profit on shareholder capital.
• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Evolving and uncertain regulatory landscape in the cannabis industry.
• Intense competition in both the cannabis and nutraceutical markets.
• Fluctuations in commodity prices could impact profitability.
• Product recalls or liability claims could damage the company's reputation and financial performance.
• Limited access to capital due to OTC market listing.

What Are the Growth Opportunities for CLVR?

• Expansion of Cannabinoid Operations: Clever Leaves has the opportunity to expand its cannabinoid operations in international markets. As more countries legalize cannabis for medicinal or recreational use, the company can leverage its existing infrastructure and expertise to enter new markets and increase its market share. The global cannabis market is projected to reach $57 billion by 2027, offering significant growth potential for Clever Leaves.
• Growth in the U.S. Nutraceutical Market: The company can capitalize on the growing demand for nutraceuticals and wellness products in the United States. By expanding its product portfolio and distribution network, Clever Leaves can increase its sales and market share in this segment. The U.S. nutraceutical market is estimated to be worth $80 billion, providing a substantial opportunity for Clever Leaves.
• Strategic Partnerships and Acquisitions: Clever Leaves can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. By partnering with other companies in the cannabis or nutraceutical industries, the company can gain access to new technologies, products, and markets. Acquisitions can also help Clever Leaves consolidate its position in key markets and increase its economies of scale.
• Product Innovation and Differentiation: Clever Leaves can invest in research and development to create innovative and differentiated products that meet the evolving needs of consumers. By developing unique formulations and delivery methods, the company can gain a competitive advantage and increase its brand recognition. This includes exploring new cannabinoid-based therapies and novel nutraceutical products.
• Regulatory Changes and Market Liberalization: Changes in regulations and market liberalization can create new opportunities for Clever Leaves. As more countries and states legalize cannabis, the company can expand its operations and access new markets. Monitoring and adapting to regulatory changes will be crucial for Clever Leaves to capitalize on these opportunities. This includes advocating for favorable regulations and participating in industry discussions.

What Are CLVR's Competitive Advantages?

• International presence in the cannabinoid market.
• Diversified product portfolio across cannabinoid and non-cannabinoid segments.
• Established distribution network in the United States.
• Expertise in cannabis cultivation and extraction.

What Does CLVR Do?

Clever Leaves Holdings Inc., established in 2017, is a cannabis company headquartered in Boca Raton, Florida. The company operates through two primary segments: Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is involved in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products on a global scale. This includes various cannabis-derived products targeted at medicinal and wellness applications. The Non-Cannabinoid segment focuses on the formulation, manufacturing, marketing, selling, and distribution of nutraceuticals, natural remedies, wellness products, detoxification products, and nutritional and dietary supplements. These products are primarily sold to mass retailers, specialty and health retailers, and distributors within the United States. Clever Leaves aims to leverage its international presence and diversified product portfolio to capture a significant share of the growing cannabis and wellness markets. However, the company faces challenges related to regulatory complexities, market competition, and achieving profitability.

What Products and Services Does CLVR Offer?

• Cultivates cannabis plants for cannabinoid extraction.
• Extracts cannabinoids from cannabis plants.
• Manufactures cannabinoid-based products.
• Commercializes and distributes cannabinoid products internationally.
• Formulates nutraceutical and wellness products.
• Markets and sells nutraceutical products in the United States.
• Distributes nutraceuticals to mass retailers, specialty stores, and distributors.

How Does CLVR Make Money?

• Cultivation and extraction of cannabinoids for sale to manufacturers and distributors.
• Manufacturing and sale of cannabinoid-based products to consumers and businesses.
• Formulation, manufacturing, and sale of nutraceutical and wellness products in the U.S.
• Distribution through mass retailers, specialty stores, and distributors.

What Industry Does CLVR Operate In?

Clever Leaves operates within the rapidly expanding cannabis and nutraceutical industries. The nutraceuticals market is also experiencing growth, fueled by rising consumer awareness of health and wellness. However, both industries are highly competitive and subject to evolving regulations. Clever Leaves competes with other cannabis producers and nutraceutical companies, facing challenges related to market access, product differentiation, and regulatory compliance.

Who Are CLVR's Key Customers?

• Cannabis product manufacturers and distributors.
• Consumers seeking cannabinoid-based products.
• Mass retailers in the United States.
• Specialty and health retailers in the United States.

The most recent 12 insider filings for Clever Leaves Holdings Inc. break down as 12 sales and 0 purchases. On net that is roughly 8K shares disposed (about $9K), a signal worth weighing alongside the fundamentals.

Return on equity for Clever Leaves Holdings Inc. stands at -55.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -57.3%, showing how much profit it generates from its asset base. A current ratio of 2.40 indicates the company holds enough short-term assets to cover its near-term obligations.

Clever Leaves Holdings Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -10.11 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Clever Leaves Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Tocancipá, CO. The company is led by CEO Andres Fajardo. CLVR has traded publicly since 2020.

CLVR Financials

CLVR Latest News

CLVR Analyst Consensus

CLVR MoonshotScore

What Investors Ask About Clever Leaves Holdings Inc. (CLVR) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources